MCID: INT038
MIFTS: 44

Interdigitating Dendritic Cell Sarcoma

Categories: Cancer diseases, Immune diseases

Aliases & Classifications for Interdigitating Dendritic Cell Sarcoma

MalaCards integrated aliases for Interdigitating Dendritic Cell Sarcoma:

Name: Interdigitating Dendritic Cell Sarcoma 12 15
Dendritic Cell Sarcoma, Interdigitating 44 73
Interdigitating Cell Sarcoma 12

Classifications:



External Ids:

Disease Ontology 12 DOID:7848
ICD10 33 C96.4
MeSH 44 D054739
NCIt 50 C9282
SNOMED-CT 68 128815007
UMLS 73 C1260326

Summaries for Interdigitating Dendritic Cell Sarcoma

Disease Ontology : 12 A histiocytic and dendritic cell cancer that effect dendritic cells.

MalaCards based summary : Interdigitating Dendritic Cell Sarcoma, also known as dendritic cell sarcoma, interdigitating, is related to liver inflammatory pseudotumor and ovarian lymphoma, and has symptoms including fatigue, fever and night sweats. An important gene associated with Interdigitating Dendritic Cell Sarcoma is CR2 (Complement C3d Receptor 2), and among its related pathways/superpathways are Complement and coagulation cascades and Immune response Lectin induced complement pathway. The drugs rituximab and Gemcitabine have been mentioned in the context of this disorder. Affiliated tissues include b cells, bone and bone marrow, and related phenotypes are Increased shRNA abundance (Z-score > 2) and Increased shRNA abundance (Z-score > 2)

Related Diseases for Interdigitating Dendritic Cell Sarcoma

Graphical network of the top 20 diseases related to Interdigitating Dendritic Cell Sarcoma:



Diseases related to Interdigitating Dendritic Cell Sarcoma

Symptoms & Phenotypes for Interdigitating Dendritic Cell Sarcoma

UMLS symptoms related to Interdigitating Dendritic Cell Sarcoma:


fatigue, fever, night sweats

GenomeRNAi Phenotypes related to Interdigitating Dendritic Cell Sarcoma according to GeneCards Suite gene sharing:

26 (show all 22)
# Description GenomeRNAi Source Accession Score Top Affiliating Genes
1 Increased shRNA abundance (Z-score > 2) GR00366-A-100 9.72 SPI1
2 Increased shRNA abundance (Z-score > 2) GR00366-A-105 9.72 PTPRC
3 Increased shRNA abundance (Z-score > 2) GR00366-A-120 9.72 SPI1
4 Increased shRNA abundance (Z-score > 2) GR00366-A-121 9.72 PTPRC SPI1
5 Increased shRNA abundance (Z-score > 2) GR00366-A-122 9.72 SPI1
6 Increased shRNA abundance (Z-score > 2) GR00366-A-124 9.72 CD163
7 Increased shRNA abundance (Z-score > 2) GR00366-A-13 9.72 SPI1
8 Increased shRNA abundance (Z-score > 2) GR00366-A-137 9.72 CD163
9 Increased shRNA abundance (Z-score > 2) GR00366-A-147 9.72 SPI1
10 Increased shRNA abundance (Z-score > 2) GR00366-A-149 9.72 CD163 PTPRC SPI1
11 Increased shRNA abundance (Z-score > 2) GR00366-A-161 9.72 SPI1
12 Increased shRNA abundance (Z-score > 2) GR00366-A-177 9.72 CD163
13 Increased shRNA abundance (Z-score > 2) GR00366-A-2 9.72 PTPRC
14 Increased shRNA abundance (Z-score > 2) GR00366-A-214 9.72 PTPRC
15 Increased shRNA abundance (Z-score > 2) GR00366-A-41 9.72 PTPRC
16 Increased shRNA abundance (Z-score > 2) GR00366-A-47 9.72 SPI1
17 Increased shRNA abundance (Z-score > 2) GR00366-A-50 9.72 PTPRC
18 Increased shRNA abundance (Z-score > 2) GR00366-A-52 9.72 CD163
19 Increased shRNA abundance (Z-score > 2) GR00366-A-74 9.72 CD163
20 Increased shRNA abundance (Z-score > 2) GR00366-A-81 9.72 CD163
21 Increased shRNA abundance (Z-score > 2) GR00366-A-83 9.72 CD163
22 Increased shRNA abundance (Z-score > 2) GR00366-A-9 9.72 CD163

MGI Mouse Phenotypes related to Interdigitating Dendritic Cell Sarcoma:

46
# Description MGI Source Accession Score Top Affiliating Genes
1 immune system MP:0005387 9.02 ARID2 CD163 CR2 PTPRC SPI1

Drugs & Therapeutics for Interdigitating Dendritic Cell Sarcoma

Drugs for Interdigitating Dendritic Cell Sarcoma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 501)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
rituximab Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 174722-31-7 10201696
2
Gemcitabine Approved Phase 4,Phase 3,Phase 2,Phase 1 95058-81-4 60750
3
Lenograstim Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 135968-09-1
4
Etoposide Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 33419-42-0 36462
5
Cisplatin Approved Phase 4,Phase 3,Phase 2,Phase 1 15663-27-1 84093 441203 2767
6
Doxorubicin Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 23214-92-8 31703
7
Mechlorethamine Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 51-75-2 4033
8
Ifosfamide Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 3778-73-2 3690
9
Vincristine Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 2068-78-2, 57-22-7 5978
10
Methotrexate Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 1959-05-2, 59-05-2 126941
11
Cytarabine Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 147-94-4 6253
12
Thiotepa Approved, Investigational Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable 52-24-4 5453
13
Cyclophosphamide Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 50-18-0, 6055-19-2 2907
14
Dexamethasone Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 50-02-2 5743
15
Prednisolone Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 50-24-8 5755
16
Methylprednisolone Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 83-43-2 6741
17
Vindesine Approved, Investigational Phase 4,Not Applicable 59917-39-4, 53643-48-4 40839
18
Epirubicin Approved Phase 4,Phase 2 56420-45-2 41867
19
Prednisone Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 53-03-2 5865
20
Crizotinib Approved Phase 4,Phase 2,Phase 1 877399-52-5 11626560 10366136 10366137 10366138 10366139 10366140 10366141
21
leucovorin Approved, Nutraceutical Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 58-05-9 143 6006
22
Folic Acid Approved, Nutraceutical, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 59-30-3 6037
23
Doxil Approved June 1999 Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 31703
24
Pirarubicin Investigational Phase 4 72496-41-4
25 Prednisolone acetate Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
26 Dexamethasone acetate Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 1177-87-3
27
Isophosphamide mustard Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 0
28 Alkylating Agents Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1
29 glucocorticoids Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
30 Methylprednisolone acetate Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
31 Methylprednisolone Hemisuccinate Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
32 Folic Acid Antagonists Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1
33 Gastrointestinal Agents Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
34 Topoisomerase Inhibitors Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1
35 Hormone Antagonists Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
36 Dermatologic Agents Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
37 Nucleic Acid Synthesis Inhibitors Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1
38 Hormones Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
39 Hormones, Hormone Substitutes, and Hormone Antagonists Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
40 Peripheral Nervous System Agents Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
41 Anti-Bacterial Agents Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1
42 Vitamin B Complex Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1
43 Antibiotics, Antitubercular Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
44 Antibodies Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1,Not Applicable
45 Immunoglobulins Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1,Not Applicable
46 Antibodies, Monoclonal Phase 4,Phase 2,Phase 3,Phase 1,Early Phase 1,Not Applicable
47 Etoposide phosphate Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1
48 Immunosuppressive Agents Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1
49 Prednisolone hemisuccinate Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
50 Prednisolone phosphate Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable

Interventional clinical trials:

(show top 50) (show all 880)
# Name Status NCT ID Phase Drugs
1 CEOP/IVE/GDP Compared With CEOP as the First-line Therapy for Newly Diagnosed Adult Patients With PTCL Unknown status NCT02533700 Phase 4 CEOP/IVE/GDP chemotherapy regimen;CEOP chemotherapy regimen for 6 cycles
2 Bone Marrow Transplantation in Treating Patients With Hematologic Cancer Completed NCT00003398 Phase 4 cyclophosphamide;thiotepa
3 Trial for the Treatment of Newly Diagnosed Mature B-Cell Acute Lymphoblastic Leukemia (B-ALL), Burkitt's Non-Hodgkin's Lymphoma (NHL) and Other High-grade Lymphoma in Adults Completed NCT00199082 Phase 4 Adriamycin;Cyclophosphamide;Cytarabine;Dexamethasone/Prednisolone;VP16;Ifosfamide;Methotrexate;G-CSF;Rituximab;Vincristine/Vindesine
4 Study of Brentuximab Vedotin in Patients With Relapsed or Refractory Systemic Anaplastic Large Cell Lymphoma Active, not recruiting NCT01909934 Phase 4 brentuximab vedotin
5 CTOP/ITE/MTX Compared With CHOP as the First-line Therapy for Newly Diagnosed Young Patients With T Cell Lymphoma Active, not recruiting NCT01746992 Phase 4 Cyclophosphamide 750mg/m2;Vincristine 1.4mg/m2;Doxorubicin 50mg/m2;prednisone 60mg/m2;ifosfamide 2000mg/m2;pirarubicin 50mg/m2;pirarubicin 25mg/m2;Etoposide phosphate 100mg/m2;methotrexate 1500mg/m2
6 A Study of Treatment ALK(+) Systemic Anaplastic Large Cell Lymphoma With Crizotinib Withdrawn NCT02487316 Phase 4 crizotinib
7 Combination Chemotherapy in Treating Children With Anaplastic Large Cell Lymphoma Unknown status NCT00006455 Phase 3 cyclophosphamide;cytarabine;dexamethasone;doxorubicin hydrochloride;etoposide;ifosfamide;leucovorin calcium;methotrexate;therapeutic hydrocortisone;vinblastine sulfate
8 Early Hospital Discharge or Standard Inpatient Care in Cancer Patients Receiving Antibiotics for Febrile Neutropenia Unknown status NCT00445497 Phase 3 amoxicillin-clavulanate potassium;ciprofloxacin
9 Ketamine Hydrochloride and Best Pain Management in Treating Cancer Patients With Neuropathic Pain Unknown status NCT01316744 Phase 3 ketamine hydrochloride
10 Combination Chemotherapy With or Without Rituximab in Treating Older Patients With Non-Hodgkin's Lymphoma Unknown status NCT00052936 Phase 3 CHOP regimen;cyclophosphamide;doxorubicin hydrochloride;prednisone;vincristine sulfate
11 Levofloxacin Compared With Cefepime in Treating Cancer Patients With Fever and Neutropenia Unknown status NCT00020865 Phase 3 cefepime hydrochloride;levofloxacin
12 Chemotherapy and Radiation Therapy Plus Bone Marrow Transplantation in Treating Patients With Aggressive Non-Hodgkin's Lymphoma Unknown status NCT00003815 Phase 3 carmustine;cyclophosphamide;cytarabine;doxorubicin hydrochloride;etoposide;melphalan;prednisolone;vincristine sulfate
13 Monoclonal Antibodies in Detecting Residual Disease in Patients Who Have Been Treated for Non-Hodgkin's Lymphoma Unknown status NCT00003338 Phase 2, Phase 3
14 Radiolabeled Monoclonal Antibody in the Detection and Staging of Patients With Non-Hodgkin's Lymphoma Unknown status NCT00003337 Phase 3
15 Combination Chemotherapy Plus Filgrastim With or Without Rituximab in Treating Older Patients With Non-Hodgkin's Lymphoma Unknown status NCT00028717 Phase 3 cyclophosphamide;doxorubicin hydrochloride;prednisone;vincristine sulfate
16 Combination Chemotherapy With or Without Idarubicin and Peripheral Stem Cell Transplantation in Treating Patients With Leukemia or Myelodysplastic Syndrome Unknown status NCT00002989 Phase 3 busulfan;cyclophosphamide;idarubicin;melphalan
17 Combination Chemotherapy in Treating Children With Non-Hodgkin's Lymphoma Unknown status NCT00003423 Phase 3 asparaginase;cyclophosphamide;cytarabine;daunorubicin hydrochloride;dexamethasone;etoposide;mercaptopurine;methotrexate;prednisolone;thioguanine;vincristine sulfate
18 Combination Chemotherapy Followed By Radiation Therapy in Treating Patients With Aggressive Non-Hodgkin's Lymphoma Unknown status NCT00053768 Phase 3 EPOCH regimen;cyclophosphamide;doxorubicin hydrochloride;etoposide;prednisone;vincristine sulfate
19 High Dose Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Intermediate- or High-Grade Non-Hodgkin's Lymphoma Unknown status NCT00003578 Phase 3 CHOP regimen;carmustine;cyclophosphamide;cytarabine;doxorubicin hydrochloride;etoposide;melphalan;prednisone;vincristine sulfate
20 Interferon Alfa-2b Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory Hodgkin's Disease or Non-Hodgkin's Lymphoma Unknown status NCT00003924 Phase 3
21 Comparison of Two Combination Chemotherapy Regimens With Either Vincristine or Vinblastine in Treating Patients With Advanced Anaplastic Large Cell Lymphoma Completed NCT00059839 Phase 3 doxorubicin hydrochloride;mercaptopurine;methotrexate;prednisone;vinblastine sulfate;vincristine sulfate
22 Stem Cell Transplantation With or Without Rituximab in Treating Patients With Relapsed or Progressive B-Cell Diffuse Large Cell Lymphoma Completed NCT00052923 Phase 3 carmustine;cyclophosphamide;etoposide
23 Combination Chemotherapy in Treating Pediatric Patients With Advanced-Stage Large Cell Lymphoma Completed NCT00002618 Phase 3 cytarabine;doxorubicin hydrochloride;leucovorin calcium;mercaptopurine;methotrexate;prednisone;vincristine sulfate
24 Two Different Methods of Collecting Stem Cells For an Autologous Stem Cell Transplant in Treating Patients With Diffuse Large Cell Lymphoma Completed NCT00566228 Phase 3
25 R-CHOP-14 Versus R-CHOP-21 and Darbepoetin Alpha in Patients Aged 60-80 Years With Diffuse Large B-cell Lymphoma Completed NCT00144755 Phase 3 Darbepoetin alfa
26 ACVBP Plus Rituximab Versus CHOP Plus Rituximab in Patients With Diffuse Large B-cell Lymphoma and Age-adjusted IPI of 1 Completed NCT00140595 Phase 3 rituximab;doxorubicin;cyclophosphamide
27 Chemotherapy and Peripheral Stem Cell Transplant With or Without Monoclonal Antibody Therapy in Treating Patients With Non-Hodgkin's Lymphoma Completed NCT00012051 Phase 3 carmustine;cisplatin;cytarabine;dexamethasone;etoposide;ifosfamide;melphalan;methotrexate
28 Combination Chemotherapy With or Without Rituximab in Treating Patients With Non-Hodgkin's Lymphoma Completed NCT00064116 Phase 3 CHOP regimen
29 Internet-Based Program With or Without Telephone-Based Problem-Solving Training in Helping Long-Term Survivors of Hematopoietic Stem Cell Transplant Cope With Late Complications Completed NCT00799461 Phase 3
30 Radiation Therapy in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma Who Have Undergone Stem Cell Transplantation Completed NCT00031668 Phase 3
31 Combination Chemotherapy With or Without Monoclonal Antibody Therapy in Treating Patients With Previously Untreated HIV-Associated Non-Hodgkin's Lymphoma Completed NCT00003595 Phase 3 CHOP regimen;cyclophosphamide;doxorubicin hydrochloride;prednisone;vincristine sulfate
32 Interleukin-2 or Observation Following Radiation Therapy, Combination Chemotherapy, and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent Non-Hodgkin's Lymphoma Completed NCT00002649 Phase 3 cyclophosphamide;etoposide
33 Personalized Information or Basic Information in Helping Patients Make Decisions About Participating in a Clinical Trial Completed NCT00750009 Phase 3
34 American Ginseng in Treating Patients With Fatigue Caused by Cancer Completed NCT00719563 Phase 3 American ginseng
35 Opioid Titration Order Sheet or Standard Care in Treating Patients With Cancer Pain Completed NCT00666211 Phase 3
36 Darbepoetin Alfa With or Without Iron in Treating Anemia Caused By Chemotherapy in Patients With Cancer Completed NCT00661999 Phase 3 sodium ferric gluconate complex in sucrose
37 Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain Completed NCT00538850 Phase 3 Fentanyl sublingual spray;Placebo
38 Ondansetron in Treating Patients With Advanced Cancer and Chronic Nausea and Vomiting Not Caused by Cancer Treatment Completed NCT00006348 Phase 3 ondansetron
39 Liposomal Amphotericin B in Treating Granulocytopenia and Persistent Unexplained Fever in Cancer Patients Completed NCT00003938 Phase 3 liposomal amphotericin B
40 Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Newly Diagnosed Aggressive Non-Hodgkin's Lymphoma Completed NCT00003215 Phase 3 CHOP regimen;cyclophosphamide;cytarabine;doxorubicin hydrochloride;etoposide;leucovorin calcium;melphalan;methotrexate;methylprednisolone;mitoxantrone hydrochloride;prednisone;therapeutic hydrocortisone;vincristine sulfate
41 St. John's Wort in Relieving Fatigue in Patients Undergoing Chemotherapy or Hormone Therapy for Cancer Completed NCT00005805 Phase 3
42 Comparison of Nutritional Supplements in Preventing Weight Loss in Patients With Cancer Completed NCT00053053 Phase 3
43 Dalteparin to Prevent Complications in Cancer Patients Receiving Chemotherapy Through a Catheter Completed NCT00006083 Phase 3 Fragmin
44 Rituximab and Combination Chemotherapy in Treating Patients With Non-Hodgkin's Lymphoma Completed NCT00278421 Phase 3 cyclophosphamide;doxorubicin hydrochloride;prednisone;vincristine sulfate
45 Rituximab and Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With B-Cell Non-Hodgkin's Lymphoma Completed NCT00278408 Phase 3 cyclophosphamide;doxorubicin hydrochloride;prednisone;vincristine sulfate
46 Darbepoetin Alfa Compared With Epoetin Alfa in Treating Anemia in Patients Receiving Chemotherapy for Cancer Completed NCT00070382 Phase 3 darbepoetin alfa;epoetin alfa
47 Caspofungin Acetate Compared With Amphotericin B Liposomal in Treating Patients With Persistent Fever and Neutropenia Following Cancer Treatment Completed NCT00008359 Phase 3 caspofungin acetate;liposomal amphotericin B
48 Levofloxacin to Prevent Infection Following Chemotherapy in Treating Patients With Solid Tumors or Lymphoma Completed NCT00005590 Phase 3 levofloxacin
49 Treatment for Chronic Pain in Patients With Advanced Cancer Completed NCT00003687 Phase 3 dextromethorphan hydrobromide;morphine sulfate
50 Prevention of Infection in Patients With Hematologic Cancer and Persistent Fever Caused by a Low White Blood Cell Count Completed NCT00003805 Phase 3 piperacillin sodium;piperacillin-tazobactam;tazobactam sodium;vancomycin

Search NIH Clinical Center for Interdigitating Dendritic Cell Sarcoma

Cochrane evidence based reviews: dendritic cell sarcoma, interdigitating

Genetic Tests for Interdigitating Dendritic Cell Sarcoma

Anatomical Context for Interdigitating Dendritic Cell Sarcoma

MalaCards organs/tissues related to Interdigitating Dendritic Cell Sarcoma:

41
B Cells, Bone, Bone Marrow, T Cells, Liver, Kidney, Myeloid

Publications for Interdigitating Dendritic Cell Sarcoma

Articles related to Interdigitating Dendritic Cell Sarcoma:

(show top 50) (show all 62)
# Title Authors Year
1
Primary jejunal interdigitating dendritic cell sarcoma. ( 29414390 )
2018
2
Interdigitating dendritic cell sarcoma: Clinicopathologic study of 8 cases with review of the literature. ( 29660568 )
2018
3
A Rare Case of Interdigitating Dendritic Cell Sarcoma of the Rectum: Review of Histopathology and Management Strategy. ( 28784918 )
2017
4
An unusual case of metachronous NK/T cell lymphoma and interdigitating dendritic cell sarcoma. ( 29043241 )
2017
5
Diffuse lesion and necrosis tied to poorer prognosis of interdigitating dendritic cell sarcoma: cases report and a pooled analysis. ( 28386111 )
2017
6
Interdigitating dendritic cell sarcoma successfully treated with ABVD therapy in which serum CEA levels correlated with disease activity. ( 28484155 )
2017
7
Interdigitating dendritic cell sarcoma: diagnostic pitfalls, treatment challenges and role of transdifferentation in pathogenesis. ( 28830690 )
2017
8
Interdigitating dendritic cell sarcoma presenting in the sigmoid colon mesentery: A case report and literature review. ( 28422825 )
2017
9
Primary cutaneous interdigitating dendritic cell sarcoma is a morphologic and phenotypic simulator of poorly differentiated metastatic melanoma: A report of 2 cases and review of the literature. ( 28302385 )
2017
10
Primary Cutaneous Interdigitating Dendritic Cell Sarcoma: A Case Report and Review of the Literature. ( 27442049 )
2016
11
Oncogene Status of an Interdigitating Dendritic Cell Sarcoma: Recurrent Mutations in NF1, TP53, and ARID2 Shared With Melanoma. ( 27680605 )
2016
12
Spindle Cell Melanoma and Interdigitating Dendritic Cell Sarcoma: Do They Represent the Same Process? ( 27299798 )
2016
13
Braf mutation in interdigitating dendritic cell sarcoma: a case report and review of the literature. ( 26047060 )
2015
14
Complete Remission in Systemic Skin Interdigitating Dendritic Cell Sarcoma after ABVD Chemotherapy. ( 26106005 )
2015
15
Challenges in the differential diagnosis of interdigitating dendritic cell sarcoma of intraparotid lymph node vs. metastatic malignant melanoma with unknown primary site. ( 25722315 )
2015
16
Interdigitating dendritic cell sarcoma. ( 25691604 )
2015
17
Head and Neck Extranodal Interdigitating Dendritic Cell Sarcoma: Case Report and Review of the Literature. ( 25893828 )
2015
18
Sustained remission after ABVD treatment for interdigitating dendritic cell sarcoma. ( 26199576 )
2015
19
Intracranial Interdigitating Dendritic Cell Sarcoma: First Case Report. ( 26237342 )
2015
20
Evidence of BRAF V600E in indeterminate cell tumor and interdigitating dendritic cell sarcoma. ( 25787243 )
2015
21
Interdigitating dendritic cell sarcoma presenting in the kidney combined with retroperitoneal leiomyosarcoma: A case report and literature review. ( 24396471 )
2014
22
Interdigitating dendritic cell sarcoma presenting in the skin: diagnosis and the role of surgical resection, chemotherapy and radiotherapy in management. ( 25568750 )
2014
23
Primary Cutaneous Interdigitating Dendritic Cell Sarcoma: A Case Report and Review of the Literature. ( 25321088 )
2014
24
The genetics of interdigitating dendritic cell sarcoma share some changes with Langerhans cell histiocytosis in select cases. ( 24321462 )
2014
25
A rare case of interdigitating dendritic cell sarcoma in the nasal cavity. ( 23710400 )
2013
26
A case of interdigitating dendritic cell sarcoma/histiocytic sarcoma - a diagnostic pitfall. ( 24427360 )
2013
27
Interdigitating dendritic cell sarcoma presenting simultaneously with acute myelomonocytic leukemia: report of a rare case and literature review. ( 23605368 )
2013
28
Interdigitating dendritic cell sarcoma and follicular dendritic cell sarcoma : histopathological findings for differential diagnosis. ( 24369219 )
2013
29
Interdigitating dendritic cell sarcoma complicated with paraneoplastic pemphigus after surgery of resection. ( 23652075 )
2013
30
Interdigitating dendritic cell sarcoma presenting in the nasal region. ( 22554504 )
2012
31
Interdigitating dendritic cell sarcoma of the liver and lung: a case report with morphohological and immunohistochemical features of tumor. ( 22938549 )
2012
32
Interdigitating dendritic cell sarcoma occured alone in axilla. ( 22563543 )
2012
33
Successful treatment of disseminated interdigitating dendritic cell sarcoma with adriamycin, bleomycin, vinblastine, and dacarbazine chemotherapy. ( 22783364 )
2012
34
Small intestine perforation due to metastatic uterine cervix interdigitating dendritic cell sarcoma: a rare manifestation of a rare disease. ( 22355501 )
2011
35
Extranodal interdigitating dendritic cell sarcoma presenting in the pleura: a case report. ( 21286027 )
2011
36
Interdigitating dendritic cell sarcoma following adult liver transplantation: case report and literature review. ( 21052884 )
2011
37
Interdigitating dendritic cell sarcoma of lymph node mimicking granuloma: a case report and review of the literature. ( 22246915 )
2011
38
Narrow-band imaging of interdigitating dendritic cell sarcoma originating in the duodenum. ( 21425001 )
2011
39
Interdigitating dendritic cell sarcoma: case report with review of the literature. ( 22104162 )
2011
40
Interdigitating dendritic cell sarcoma of the ileum recurred in multiple lymph nodes and duodenum three years after operation without chemotherapy. ( 20399026 )
2010
41
Interdigitating dendritic cell sarcoma involving bone marrow in a liver transplant recipient. ( 20620556 )
2010
42
BCL2 chromosomal translocation is not a general feature of the interdigitating dendritic cell sarcoma. ( 20736747 )
2010
43
Interdigitating dendritic cell sarcoma of the tonsil. ( 20887493 )
2010
44
Molecular characterization of interdigitating dendritic cell sarcoma. ( 21139965 )
2010
45
Metastatic interdigitating dendritic cell sarcoma masquerading as a skin primary tumor: a case report and review of the literature. ( 19155734 )
2009
46
Transformation of chronic lymphocytic leukemia/small lymphocytic lymphoma to interdigitating dendritic cell sarcoma: evidence for transdifferentiation of the lymphoma clone. ( 19926586 )
2009
47
Interdigitating dendritic cell sarcoma of the leg. ( 19521127 )
2009
48
[Interdigitating dendritic cell sarcoma of lower extremities resistant to high dose chemotherapy BEAM with peripheral blood stem cell transplantation]. ( 19348397 )
2009
49
Interdigitating dendritic cell sarcoma of the parotid gland: case report and literature review. ( 19563939 )
2009
50
Interdigitating dendritic cell sarcoma of the eyelid with a rapidly fatal course. ( 18474795 )
2008

Variations for Interdigitating Dendritic Cell Sarcoma

Expression for Interdigitating Dendritic Cell Sarcoma

Search GEO for disease gene expression data for Interdigitating Dendritic Cell Sarcoma.

Pathways for Interdigitating Dendritic Cell Sarcoma

GO Terms for Interdigitating Dendritic Cell Sarcoma

Cellular components related to Interdigitating Dendritic Cell Sarcoma according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 secretory granule membrane GO:0030667 8.62 CR1 PTPRC

Biological processes related to Interdigitating Dendritic Cell Sarcoma according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 regulation of complement activation GO:0030449 9.26 CR1 CR2
2 viral entry into host cell GO:0046718 9.16 CR1 CR2
3 B cell proliferation GO:0042100 8.96 CR2 PTPRC
4 complement receptor mediated signaling pathway GO:0002430 8.62 CR1 CR2

Molecular functions related to Interdigitating Dendritic Cell Sarcoma according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 virus receptor activity GO:0001618 8.62 CR1 CR2

Sources for Interdigitating Dendritic Cell Sarcoma

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 ExPASy
19 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 LOVD
42 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
54 NINDS
55 Novoseek
57 OMIM
58 OMIM via Orphanet
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 SNOMED-CT via Orphanet
71 TGDB
72 Tocris
73 UMLS
74 UMLS via Orphanet
Content
Loading form....